Mostrar el registro sencillo del ítem
Acceptability and feasibility of home and hospital follow-up in Burkina Faso and Guinea: A mixed-method study among patients of the COVID-19 Coverage-Africa clinical trial
dc.rights.license | open | en_US |
hal.structure.identifier | Bordeaux population health [BPH] | |
hal.structure.identifier | Global Health in the Global South [GHiGS] | |
dc.contributor.author | PLAZY, Melanie | |
dc.contributor.author | DOUCET, Marie-Hélène | |
dc.contributor.author | TIMBO SONGBONO, Christine | |
dc.contributor.author | SANON, Anselme | |
dc.contributor.author | ISSIAKA, Bamba | |
dc.contributor.author | MARTIN, Caroline | |
dc.contributor.author | DA, Inès | |
dc.contributor.author | L'HOSTELLIER, Anthony | |
hal.structure.identifier | Bordeaux population health [BPH] | |
hal.structure.identifier | Global Health in the Global South [GHiGS] | |
dc.contributor.author | MARCY, Olivier | |
hal.structure.identifier | Bordeaux population health [BPH] | |
hal.structure.identifier | Global Health in the Global South [GHiGS] | |
dc.contributor.author | MALVY, Denis
ORCID: 0000-0003-1948-9355 IDREF: 148480993 | |
dc.contributor.author | PODA, Armel | |
dc.contributor.author | DELAMOU, Alexandre | |
dc.contributor.author | BERTHÉ, Abdramane | |
hal.structure.identifier | Bordeaux population health [BPH] | |
hal.structure.identifier | Global Health in the Global South [GHiGS] | |
dc.contributor.author | ORNE-GLIEMANN, Joanna | |
dc.date.accessioned | 2023-10-17T09:53:26Z | |
dc.date.available | 2023-10-17T09:53:26Z | |
dc.date.issued | 2023-07-12 | |
dc.identifier.issn | 2767-3375 | en_US |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/184458 | |
dc.description.abstractEn | Patient experiences and perspectives on trial participation and follow-up may influence their compliance with research procedures or negatively impact their well-being. We aimed to explore the acceptability and feasibility of home-based and hospital-based follow-up modalities among COVID-19 patients enrolled in the ANTICOV ANRS COV33 Coverage-Africa trial in Burkina Faso and Guinea. The trial (2021-2022) evaluated the efficacy of treatments to prevent clinical worsening among COVID-19 patients with mild to moderate symptoms. Patients were either based at home or hospitalized, as per national recommendations, and followed-up through face-to-face visits and phone calls. We conducted a mixed-methods sub-study administering a questionnaire to all consenting participants and individually interviewing purposively selected participants. We performed descriptive analyses of Likert scale questions for the questionnaires and thematic analysis for the interviews. We conducted framework analysis and interpretation. Of the 400 trial patients, 220 completed the questionnaire (n = 182 in Burkina Faso, n = 38 in Guinea) and 24 were interviewed (n = 16 and n = 8, respectively). Participants were mostly followed-up at home in Burkina Faso; all patients from Guinea were first hospitalized, then followed-up at home. Over 90% of participants were satisfied with follow-up. Home follow-up was considered acceptable if (i) participants perceived they were not severely ill, (ii) it was combined with telemedicine, and (iii) the risk of stigma could be avoided. Hospital-based follow-up was viewed as a way to prevent contamination of family members, but could be badly experienced when mandatory and conflicting with family responsibilities and commitments. Phone calls were seen as reassuring and as a way to ensure continuity of care. These overall positive findings support the development of home-based follow-up for mildly ill patients in West-Africa, provided that both emotional and cognitive factors at individual, familial/inter-relational, healthcare and national levels be addressed when planning the implementation of a trial, or developing any public health strategy. | |
dc.language.iso | EN | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.title.en | Acceptability and feasibility of home and hospital follow-up in Burkina Faso and Guinea: A mixed-method study among patients of the COVID-19 Coverage-Africa clinical trial | |
dc.title.alternative | PLOS Glob Public Health | en_US |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.1371/journal.pgph.0001545 | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
dc.identifier.pubmed | 37437024 | en_US |
bordeaux.journal | PLOS Global Public Health | en_US |
bordeaux.page | e0001545 | en_US |
bordeaux.volume | 3 | en_US |
bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
bordeaux.issue | 7 | en_US |
bordeaux.institution | Université de Bordeaux | en_US |
bordeaux.institution | INSERM | en_US |
bordeaux.team | GHIGS | en_US |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
bordeaux.identifier.funderID | Agence Nationale de Recherches sur le Sida et les Hépatites Virales | en_US |
bordeaux.identifier.funderID | Institut de Recherche pour le Développement | en_US |
bordeaux.identifier.funderID | European and Developing Countries Clinical Trials Partnership | en_US |
bordeaux.identifier.funderID | Starr Foundation | en_US |
bordeaux.identifier.funderID | Stavros Niarchos Foundation | en_US |
bordeaux.import.source | pubmed | |
hal.identifier | hal-04245828 | |
hal.version | 1 | |
hal.date.transferred | 2023-10-17T09:53:29Z | |
hal.popular | non | en_US |
hal.audience | Internationale | en_US |
hal.export | true | |
workflow.import.source | pubmed | |
dc.rights.cc | Pas de Licence CC | en_US |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=PLOS%20Global%20Public%20Health&rft.date=2023-07-12&rft.volume=3&rft.issue=7&rft.spage=e0001545&rft.epage=e0001545&rft.eissn=2767-3375&rft.issn=2767-3375&rft.au=PLAZY,%20Melanie&DOUCET,%20Marie-H%C3%A9l%C3%A8ne&TIMBO%20SONGBONO,%20Christine&SANON,%20Anselme&ISSIAKA,%20Bamba&rft.genre=article |